Is this your firm? Get featured or correct your listing →
Strategy
Portfolio
2 totalRecent Investment Activity
1Track record: led 0 and participated in 1 of 1 tracked venture round · 1 in the last 12 months
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | Epicrispr Biotechnologies | Series C | Participated | $90M | — | Janus Henderson InvestorsLeadunverifiedFidelity InvestmentsunverifiedCormorant Asset ManagementunverifiedSanofi VenturesunverifiedOctagon Capital | Epicrispr Biotechnologies |
Co-Investors
8Similar Firms
overlapping sector, stage or regionLatest Pulse
Cormorant Asset Management FAQ
What companies has Cormorant Asset Management invested in?
Cormorant Asset Management's portfolio includes Epicrispr Biotechnologies, Triveni Bio.
Who does Cormorant Asset Management co-invest with most?
In the rounds Value Add tracks, Cormorant Asset Management most often invests alongside Fidelity Investments (2 shared deals), Janus Henderson Investors (2 shared deals), Ascenta Capital (1 shared deal), Atlas Venture (1 shared deal), Deep Track Capital (1 shared deal).
Sources & methodologyshow
- Epicrispr BiotechnologiesValue Add VC data1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.